News for Cancer

Cancer Research UK’s Drug Development Office has opened the first trial of a new drug combination in patients with advanced solid tumours and in a subset of patients who have non-small cell lung cancer. This trial will combine two compounds that aim to starve the tumours while simultaneously ... READ MORE

A collection of three papers (two published in The Lancet and one in The Lancet Oncology) add to the growing evidence base suggesting that daily aspirin can be used to help prevent and possibly treat cancer.  All three papers are by Professor Peter Rothwell, University of Oxford and John Radcliffe ... READ MORE

On 14th March 2012 the NIHR Biomedical Research Centre and the Oxford Cancer Research Centre (right) hosted a public open day on research that is designed to improve health.  A morning session was held for secondary schools, introducing them to the world of cancer research.  Scientists, doctors, ... READ MORE

Doctors, surgeons and researchers from the Imaging Theme of the NIHR Biomedical Research Centre, Oxford are looking into the effectiveness of using ablation as another treatment option for lung, liver and renal tumours. Microwave Ablation is used to treat small tumors by passing ... READ MORE

A CANCER RESEARCH UK-funded trial of a new drug for patients with advanced breast or ovarian cancer due to inherited gene faults has been launched at the Oxford Experimental Cancer Medicine Centre (ECMC) at the University of Oxford. The trial, led by a team based at the National Institute for ... READ MORE

While they may be small in size, a family of tiny molecules called microRNAs could potentially play a large role in the process of cancer metastasis, or the spread of cancer from one area of the body to another. A team of researchers from The Cancer Institute of New Jersey (CINJ) and Princeton ... READ MORE

Researchers at the University of Oxford have developed a cheap and reliable diagnostic test for a rare form of cancer. The test involves screening tumour samples for a particular molecular fingerprint unique to this cancer. Hereditary leiomyomatosis and renal cell cancer (HLRCC) is a disorder ... READ MORE

Last December, Kevin Jones, a 43-year-old businessman from Dorset was diagnosed with pancreatic cancer. It was advanced and inoperable. Today, as he prepares to celebrate Christmas with his son, Mr Jones is free from any detectable trace of the disease; the human face of a medical breakthrough so ... READ MORE

Taking a low-dose aspirin every day will reduce your chances of dying from cancer, scientists say today, confirming the over-the-counter pill as the most extraordinary drug yet discovered. Daily aspirin has already been shown to cut the chances of heart attacks and stroke in people who are at ... READ MORE

Professor Peter Rothwell, of the John Radcliffe Hospital, Oxford, and Oxford University, describes the findings of a recent study, tipping the balance in favour of regular aspirin ... READ MORE

Researchers at Immunocore Limited today announced that IMCgp100, a targeted therapeutic for the treatment of advanced metastatic melanoma, has received regulatory and ethics approval and has opened enrolment for clinical trials in the England and USA. IMCgp100 is the first clinical candidate ... READ MORE

Professor Mark Middleton, Professor John Bell, Dr Jenny Taylor and research colleagues from Oxford were interviewed on BBC Radio 4 on 17 February about new generations of cancer drugs. Discussions centred around advances in tumour mapping, patients' experiences, advances in genetic testing and ... READ MORE